Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Alvaro Arjona‐Sanchez"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bahar Canbay Torun, Olivier Glehen, Vahan Kepenekian, Armando Sardi, Alvaro Arjona-Sanchez, Yutaka Yonemura, Shoma Barat, David Morris, John Spiliotis, Federico Coccolini, Antonio Sommariva, Adrian Bartos, Sayyed Raza, Kurt Vander Speteen, Levhi Akin, Tulay Irez, Emel Canbay, Naoual Bakrin, Laurent Villeneuve, Raquel Barrios-Campal, Lidia Rodriguez-Ortiz, Luliu Hațieganu
Publikováno v:
European Journal of Surgical Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ff948fffd22d247f2f83dc84cd2ad2b
https://doi.org/10.1016/j.ejso.2023.03.214
https://doi.org/10.1016/j.ejso.2023.03.214
Autor:
Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, María Trinidad Moreno‐Montilla, Víctor García‐Vioque, Juan Manuel Jiménez‐Vacas, Andrea Mafficini, Iranzu González‐Borja, Claudio Luchini, Juan M. Sánchez‐Hidalgo, Marina E. Sánchez‐Frías, Sergio Pedraza‐Arevalo, Antonio Romero‐Ruiz, Rita T. Lawlor, Antonio Viúdez, Manuel D. Gahete, Aldo Scarpa, Álvaro Arjona‐Sánchez, Raúl M. Luque, Alejandro Ibáñez‐Costa, Justo P. Castaño
Publikováno v:
Molecular Oncology, Vol 18, Iss 10, Pp 2524-2540 (2024)
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer, characterized by late diagnosis and poor treatment response. Surgery is the only curative approach, only available to early‐diagnosed patients. Current therapies have limited effect
Externí odkaz:
https://doaj.org/article/de947d6fca6d49f9911a2528b10949ca
Autor:
Antonio Romero-Ruiz, Melissa Granados-Rodríguez, Florina I. Bura, Francisca Valenzuela-Molina, Blanca Rufián-Andújar, Ana Martínez-López, Lidia Rodríguez-Ortiz, Rosa Ortega-Salas, María Torres-Martínez, Ana Moreno-Serrano, Justo Castaño, Carmen Michán, José Alhama, Mari C. Vázquez-Borrego, Álvaro Arjona-Sánchez
Publikováno v:
Biological Procedures Online, Vol 26, Iss 1, Pp 1-17 (2024)
Abstract Background Pseudomyxoma peritonei (PMP) is a rare peritoneal mucinous carcinomatosis with largely unknown underlying molecular mechanisms. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy is the only therapeutic
Externí odkaz:
https://doaj.org/article/8c7758467bfe40caa8da8c69828f0e29
Autor:
José Manuel Pérez-de-Villar, Alvaro Arjona-Sanchez, Blanca Rufián-Andujar, Francisca Valenzuela-Molina, Juan Manuel Sánchez-Hidalgo, Lidia Rodriguez-Ortiz, Angela Casado-Adam, Cristina Viyuela-García, Sebastián Rufián-Peña, Teresa Caro-Cuenca, Alberto Moreno-Vega, Javier Briceño-Delgado
Publikováno v:
Cirugia espanola. 100(8)
Primary tumors of the inferior vena cava are rare tumors of mesenchymal origin. They arise from the smooth muscles of the vena cava wall. Due to its low prevalence, there are few definitive data on its treatment and prognosis. Its treatment is based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d83361a633716eaefa651c2452f934e6
https://pubmed.ncbi.nlm.nih.gov/35597419
https://pubmed.ncbi.nlm.nih.gov/35597419
Autor:
Blanca Rufian‐Andujar, Juan Manuel Sanchez‐Hidalgo, Lidia Rodriguez‐Ortiz, Alvaro Arjona‐Sanchez, Sebastian Rufian‐Peña, Francisco Javier Briceño‐Delgado
Publikováno v:
Colorectal Disease. 24:1093-1093
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::713faaf788f63a56361cbf3bd23e8d9c
https://doi.org/10.1111/codi.16138
https://doi.org/10.1111/codi.16138
Autor:
Mari C. Vázquez-Borrego, Melissa Granados-Rodríguez, Florina I. Bura, Ana Martínez-López, Blanca Rufián-Andújar, Francisca Valenzuela-Molina, Lidia Rodríguez-Ortiz, Sergio Haro-Yuste, Ana Moreno-Serrano, Rosa Ortega-Salas, Rafael Pineda-Reyes, Carmen Michán, José Alhama, Antonio Romero-Ruiz, Álvaro Arjona-Sánchez
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-5 (2023)
Abstract Pseudomyxoma peritonei (PMP) is a rare disease characterized by a massive accumulation of mucus in the peritoneal cavity. The only effective treatment is aggressive surgery, aimed at removing all visible tumors. However, a high percentage of
Externí odkaz:
https://doaj.org/article/057e25907a00419ab08d142aff5eb0aa
Autor:
Emilia Alors-Pérez, Sergio Pedraza-Arevalo, Ricardo Blázquez-Encinas, Víctor García-Vioque, Antonio Agraz-Doblas, Elena M. Yubero-Serrano, Marina E. Sánchez-Frías, Raquel Serrano-Blanch, María Ángeles Gálvez-Moreno, Francisco Gracia-Navarro, Manuel D. Gahete, Álvaro Arjona-Sánchez, Raúl M. Luque, Alejandro Ibáñez-Costa, Justo P. Castaño
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 35, Iss 1, Pp 102090- (2024)
Pancreatic neuroendocrine tumors (PanNETs) comprise a heterogeneous group of tumors with growing incidence. Recent molecular analyses provided a precise picture of their genomic and epigenomic landscape. Splicing dysregulation is increasingly regarde
Externí odkaz:
https://doaj.org/article/46b3eb5e3ec743c68155cde95dd29e80
Autor:
Alvaro Arjona-Sanchez
Publikováno v:
Digestive Medicine Research. 3:19-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4b629bcb4ac81b617ff381fb9d5628c
https://doi.org/10.21037/dmr-20-35
https://doi.org/10.21037/dmr-20-35
Autor:
Fernando Pereira, Angel Serrano, Israel Manzanedo, Estibalitz Pérez-Viejo, Santiago González-Moreno, Luis González-Bayón, Alvaro Arjona-Sánchez, Juan Torres, Isabel Ramos, Maria E. Barrios, Pedro Cascales, Rafael Morales, Enrique Boldó, Alfonso García-Fadrique, Xabier Arteaga, Alberto Gutierrez-Calvo, Susana Sánchez-García, Enrique Asensio, Cesar P. Ramírez, Manuel Artiles, Javier Vaqué, Pedro A. Parra, Pedro Villarejo, Cristóbal Muñoz-Casares, Estrella Turienzo, Alicia Calero, Isabel Jaén Torrejimeno, Isabel Prieto, Julio Galindo, Vicente Borrego, Manuel E. Marcello, Cristina Rihuete, Joaquin Carrasco, Luis Gomez-Quiles
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background The French PRODIGE 7 trial, published on January 2021, has raised doubts about the specific survival benefit provided by HIPEC with oxaliplatin 460 mg/m2 (30 minutes) for the treatment of peritoneal metastases from colorectal canc
Externí odkaz:
https://doaj.org/article/0ea95b90f8f840e4862d548b694593da